AFT Pharmaceuticals Limited
NZSE:AFT
$ 2.85
+ $0.01 (0.35%)
$ 2.85
+ $0.01 (0.35%)
End-of-day quote: 05/17/2024

AFT Pharmaceuticals financials at a glance

The revenue of AFT Pharmaceuticals is reported as 0.15664 billion Dollars in the fiscal year 2024. The earnings were 0.1 Dollars per share in 2024, which was 47.37 lower than 2022. And about 0.00245 billion Dollars are reported as free cash flow in the financials of AFT Pharmaceuticals 2024. Dividends of 0 Dollars per share were paid to shareholders of AFT Pharmaceuticals stock NZSE:AFT in fiscal 2024.

$156.64M
Revenue
$0.10
Earnings Per Share
46.59%
Gross Margin %
$2.45M
Free Cash Flow
Revenue
156.64
Earnings Per Share
0.10
Gross Margin %
46.59
Free Cash Flow
2.45

Financials

Year Year TTM 2023 2022 2021 2020 2019 2018 2017 2016 2015
Rev. Revenue N/A $156.64M $130.31M $113.11M $105.60M $85.13M $80.07M $69.21M $64.01M $0.00M
GM % Gross Margin % 45.98% 46.59% 47.40% 43.09% 45.71% 47.85% 43.48% 37.57% 36.83% 0.00%
OM Operating Margin 11.15% 12.56% 15.65% 9.47% 10.89% 7.80% -10.65% -21.58% -13.52% 0.00%
EPS Earnings Per Share $0.15 $0.10 $0.19 $0.07 $0.05 $-0.03 $-0.13 $-0.19 $-0.16 $-10.91
Div. Dividends N/A $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio % 0 0.00% 0.00% 0.00% 0.00% -0.00% -0.00% -0.00% -0.00% 0
Sha. Shares N/AM 104.87M 104.71M 104.64M 97.43M 97.31M 97.31M 96.83M 96.83M 81.82M
OCF Operating Cash Flow N/A $11.63M $14.15M $0.75M $0.00M $1.07M $0.00M $-19.06M $0.00M $0.00M
FCF Free Cash Flow N/A $2.45M $8.57M $-5.48M $0.00M $0.93M $0.00M $-19.18M $0.00M $0.00M
FCFS Free Cash Flow Per Share $0.05 $0.02 $0.08 $-0.05 $0.08 $-0.03 $-0.13 $-0.20 $-0.59 $0.00